Published mark
Dexcom
DEXCOM INC
NASDAQ: DXCM. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:9a960e1e-46de-48e7-89b2-f3cfdecf43f5
- SEC CIK
- 0001093557
- Website
- www.dexcom.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Apr 15, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Not published
- Chair
- Not published
- Independent
- 10 / 1212 directors published
- Published claims
- 446 distinct sources
- Evidence records
- 70 pinned
- Source conflicts
- 0None open
Built from 6 distinct sources and 7 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Jacob Leach seat on Dexcom, effective 2026-01-01.
EffectiveEffective Jan 1, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Board of directors
Evidence12 directors published. 10 of 12 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Bridgette Heller | Independent | 2019 | Compensation, chairCompensation · Chair | Source reportedE3 |
| Euan Ashley | Independent | 2025 | Nominating and GovernanceNominating and Governance; TechnologyTechnology | Source reportedE3 |
| Jacob Leach | Not independent | 2026 | None published | Source reportedE3 |
| Kevin Sayer | Not independent | 2007 | None published | Source reportedE3 |
| Kyle Malady | Independent | 2020 | Technology, chairTechnology · Chair | Source reportedE3 |
| Mark Foletta | Independent | 2014 | Audit, chairAudit · Chair | Source reportedE3 |
| Nicholas Augustinos | Independent | 2009 | Nominating and Governance, chairNominating and Governance · Chair | Source reportedE3 |
| Rene Gal | Independent | 2025 | AuditAudit; CompensationCompensation | Source reportedE3 |
| Richard Collins | Independent | 2017 | AuditAudit; Nominating and GovernanceNominating and Governance | Source reportedE3 |
| Rick Osterloh | Independent | 2026 | CompensationCompensation; TechnologyTechnology | Source reportedE3 |
| Rimma Driscoll | Independent | 2023 | AuditAudit; TechnologyTechnology | Source reportedE3 |
| Steven Altman | Independent | 2013 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE3 |
| Karen Dahut | Independence not published | Not published | CompensationTechnology | Source reportedE5 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Mark Foletta | Mark Foletta, Rene Gal, Richard Collins, Rimma Driscoll | Not described in the published record |
| Audit · Chair | Not published | Mark Foletta | Not described in the published record |
| Audit; Compensation | Not published | Rene Gal | Not described in the published record |
| Audit; Nominating and Governance | Not published | Richard Collins | Not described in the published record |
| Audit; Technology | Not published | Rimma Driscoll | Not described in the published record |
| Compensation | Bridgette Heller | Bridgette Heller, Karen Dahut, Rene Gal, Rick Osterloh, Steven Altman | Not described in the published record |
| Compensation · Chair | Not published | Bridgette Heller | Not described in the published record |
| Compensation; Nominating and Governance | Not published | Steven Altman | Not described in the published record |
| Compensation; Technology | Not published | Rick Osterloh | Not described in the published record |
| Nominating and Governance | Nicholas Augustinos | Nicholas Augustinos, Euan Ashley, Richard Collins, Steven Altman | Not described in the published record |
| Nominating and Governance · Chair | Not published | Nicholas Augustinos | Not described in the published record |
| Nominating and Governance; Technology | Not published | Euan Ashley | Not described in the published record |
| Technology | Kyle Malady | Kyle Malady, Euan Ashley, Karen Dahut, Rick Osterloh, Rimma Driscoll | Not described in the published record |
| Technology · Chair | Not published | Kyle Malady | Not described in the published record |
Committee RecordAudit: Chair Mark Foletta; Members Mark Foletta (Chair); Rene Gal; Richard Collins; Rimma Driscoll
Committee AppointmentMark Foletta: chair, Audit
Committee AppointmentRene Gal: member, Audit
Committee AppointmentRichard Collins: member, Audit
Committee AppointmentRimma Driscoll: member, Audit
Committee AppointmentBridgette Heller: chair, Compensation
Committee AppointmentKaren Dahut: member, Compensation
Committee AppointmentRene Gal: member, Compensation
Committee AppointmentRick Osterloh: member, Compensation
Committee AppointmentSteven Altman: member, Compensation
Committee RecordNominating and Governance: Chair Nicholas Augustinos; Members Nicholas Augustinos (Chair); Euan Ashley; Richard Collins; Steven Altman
Committee AppointmentNicholas Augustinos: chair, Nominating and Governance
Committee AppointmentEuan Ashley: member, Nominating and Governance
Committee AppointmentRichard Collins: member, Nominating and Governance
Committee AppointmentSteven Altman: member, Nominating and Governance
Committee RecordTechnology: Chair Kyle Malady; Members Kyle Malady (Chair); Euan Ashley; Karen Dahut; Rick Osterloh; Rimma Driscoll
Committee AppointmentKyle Malady: chair, Technology
Committee AppointmentEuan Ashley: member, Technology
Committee AppointmentKaren Dahut: member, Technology
Committee AppointmentRick Osterloh: member, Technology
Committee AppointmentRimma Driscoll: member, Technology
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Index MembershipNasdaq-100 (NDX)
Security ListingDXCM (NASDAQ)
Index memberships2 memberships attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPXNDX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NASDAQ: DXCM | current | May 12, 2020 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
| Nasdaq-100 (Nasdaq) | NASDAQ: DXCM | current | Sep 1, 2026 | exchange verified | Nasdaq official Nasdaq-100 list-type API |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameDEXCOM INC
Entity StatusPublic listing published
Official Websitehttps://www.dexcom.com
Published FactUS
Published FactDE
Published FactHealthcare
Published Facthttps://www.dexcom.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- LeadershipNot reviewed. Executive leadership carries operating authority.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Bridgette HellerDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:9
- Euan AshleyDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:10
- Jacob LeachDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:11
- Kevin SayerDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:12
- Kyle MaladyDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:13
- Mark FolettaDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:14
- Nicholas AugustinosDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:15
- Rene GalDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:16
- Richard CollinsDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:17
- Rick OsterlohDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:18
- Rimma DriscollDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:19
- Steven AltmanDirectorcompany:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:leadership_role:20
- Karen DahutDirector (committee appointment)company:9a960e1e-46de-48e7-89b2-f3cfdecf43f5:committee_record:26
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 7 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 6 Claims.
- E2DEXCOM INC Form 10-K (filed 2026-02-12). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Apr 15, 2026. Retrieved May 3, 2026. Cited by 12 Claims.
- E4board_seats. board seats. Cited by 10 Claims.
- E5board_seats. board seats. Cited by 12 Claims.
- E6Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
- E7Nasdaq official Nasdaq-100 list-type API. index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Jacob Leach seat on Dexcom, effective 2026-01-01.
- Rick Osterloh seat on Dexcom, effective 2026-01-01.
- Compensation; Technology committee of Dexcom, effective 2026-01-01.
- Rick Osterloh member of Compensation; Technology, effective 2026-01-01.
- Euan Ashley seat on Dexcom, effective 2025-01-01.
- Rene Gal seat on Dexcom, effective 2025-01-01.
- Audit; Compensation committee of Dexcom, effective 2025-01-01.
- Rene Gal member of Audit; Compensation, effective 2025-01-01.
- Nominating and Governance; Technology committee of Dexcom, effective 2025-01-01.
- Euan Ashley member of Nominating and Governance; Technology, effective 2025-01-01.
- Rimma Driscoll seat on Dexcom, effective 2023-01-01.
- Audit; Technology committee of Dexcom, effective 2023-01-01.
- Rimma Driscoll member of Audit; Technology, effective 2023-01-01.
- Kyle Malady seat on Dexcom, effective 2020-01-01.
- Technology · Chair committee of Dexcom, effective 2020-01-01.
- Kyle Malady member of Technology · Chair, effective 2020-01-01.
- Bridgette Heller seat on Dexcom, effective 2019-01-01.
- Compensation · Chair committee of Dexcom, effective 2019-01-01.
- Bridgette Heller member of Compensation · Chair, effective 2019-01-01.
- Richard Collins seat on Dexcom, effective 2017-01-01.
- Audit; Nominating and Governance committee of Dexcom, effective 2017-01-01.
- Richard Collins member of Audit; Nominating and Governance, effective 2017-01-01.
- Mark Foletta seat on Dexcom, effective 2014-01-01.
- Audit · Chair committee of Dexcom, effective 2014-01-01.
- Mark Foletta member of Audit · Chair, effective 2014-01-01.
- Steven Altman seat on Dexcom, effective 2013-01-01.
- Compensation; Nominating and Governance committee of Dexcom, effective 2013-01-01.
- Steven Altman member of Compensation; Nominating and Governance, effective 2013-01-01.
- Nicholas Augustinos seat on Dexcom, effective 2009-01-01.
- Nominating and Governance · Chair committee of Dexcom, effective 2009-01-01.
- Nicholas Augustinos member of Nominating and Governance · Chair, effective 2009-01-01.
- Kevin Sayer seat on Dexcom, effective 2007-01-01.